Skip to main content

Attendees

Sarah Carr*    (SC)    Vet & Farmer/Animal Health & Welfare Framework Group Representative
Rob Smith*    (RS)    Iechyd Da/Arwain DGC
Meryl  Davies*    (MD)    Public Health Wales (PHW)
Catrin Moore*    (CM)    Microbiology Society
Ifan Lloyd*    (IL)    Iechyd Da/Arwain DGC
Mary Nelson    (MN)    Veterinary Medicines Directorate (VMD)
Tamsin Dewé    (TD)    Veterinary Medicines Directorate (VMD)
Jim Scott-Bauman    (JSB)    Small Animal Vet
Steve Howard    (SH)    RUMA Companion Animal Group
Gwyn Jones    (GJ)    RUMA Companion Animal Group
Alison Bard    (AB)    Arwain DGC
Alan Radford    (NW)    University of Liverpool
Simon Rolfe    (SR)    HSS, Welsh Government
Sian Timms    (ST)    OCVO, Welsh Government
Kirsty Falcus    (KF)    OCVO, Welsh Government
Natasha Hands    (NH)    PhD Placement, OCVO, Welsh Government
Richard Irvine    (RI)    Chief Veterinary Officer, OCVO, Welsh Government
 

Apologies

Gwen Rees*    (GR)    Aberystwyth University/Arwain DGC
Kitty Healey*    (KH)    Veterinary Medicines Directorate (VMD)
Chris Teale*    (CT)    Animal and Plant Health Agency (APHA)
Muna Anjum    (MA)    Animal and Plant Health Agency (APHA)
Peter Jones    (PJ)    HSS, Welsh Government
Thomas Bletcher*    (TB)    Farmer
Hywel Morgan*    (HM)    Farmer
Ifan Davies*    (ID)    YFC Representative
Richard Pizzey*    (RP)    OCVO, Welsh Government
Natalie Sampson    (NS)    OCVO, Welsh Government
 

Facilitator: please contact waeamrdg@gov.wales

KEY

* = DG Board Member

Welcome and Introductions: Sian Timms

Sian Timms opened the meeting by welcoming all attendees and thanking them for their efforts in traveling to Cardiff. General housekeeping matters were addressed. Apologies were noted from Richard Pizzey, who was unable to attend due to recovery from an accident.

Roundtable Updates

DG Members

Sarah Carr has confirmed that updates were communicated to the Wales Animal Health and Welfare Framework Group. The group is currently evaluating the inclusion of antimicrobial usage as a potential indicator within the Sustainable Farming Scheme.

Rob Smith provided a comprehensive overview of the initiatives currently being implemented by Arwain DGC. He delivered updates on the VPC network, detailed the ongoing collection of antimicrobial usage data, and reported on the environmental sampling activities conducted at Bristol University.

Meryl Davies provided the group with updates on recent AMR awareness activities, including the World Antimicrobial Awareness Week held from 18 to 24 November. Campaigns involved social media outreach, case studies on recurrent infections, and collaborations with universities and hospitals to highlight antimicrobial resistance issues in both humans and the environment. Efforts to engage Scottish colleagues and the launch of a Welsh version of an AMR mascot named "Bryn" were also discussed, emphasizing the importance of public engagement and education in combating AMR.

Catrin Moore provided an overview of the microbiology society’s "Knocking Out AMR" programme highlighted its extensive cross-disciplinary events, public engagement across multiple countries, and professional development sessions. The programme has influenced UK and Irish AMR policies, hosted parliamentary workshops, and contributed to consultations on diagnostics, therapeutics, vaccines, and surveillance. Upcoming events include sessions at the annual conference and a workshop on therapeutics and AMR, with a focus on early career researchers.

At this stage of the meeting, Ifan Lloyd was unavailable to present an update.

Welsh Government and One Health Updates: Sian Timms and Simon Rolfe

Welsh Government representatives reported on their contributions to the One Health subgroup and their coordination of AMR activities, including lighting government buildings blue for the WHO ‘Go Blue’ campaign. The importance of leveraging governance structures for AMR programme management was emphasized, alongside discussions on clinical presentations such as recurrent urinary tract infections in humans and the antibiotics used being found in animals, suggesting a One Health approach to these issues. The challenges of integrating AMR into linear programme structures were acknowledged, with calls for outcome-focused clinical frameworks.

Veterinary Medicines Directorate (VMD): Tamsin Dewé

The VMD provided updates on the latest AMR surveillance reports in animals, noting positive trends such as declines in resistance over ten years linked to reduced antibiotic use in food-producing animals. New targets for companion animal AMR reduction are progressing through governmental processes. Internationally, the World Organisation for Animal Health is updating its guidelines on veterinary vaccines, which will impact AMR control strategies. Education initiatives targeting veterinary professionals are in development, with a consensus document expected in February.

Arwain DGC Study Tour: Rob Smith

A significant portion of the meeting was dedicated to sharing insights from a study tour to the Netherlands, focusing on dairy and veal calf farming practices. The tour revealed advanced antibiotic stewardship, including a 70% reduction in antibiotic use since 2009, achieved through close vet-farmer collaboration, strict prescription controls, and regular farm visits. Challenges such as higher mortality rates linked to reduced antibiotic use were discussed, highlighting the complexity of balancing animal health and AMR reduction. 

The integration of government and industry efforts, supported by legislation and benchmarking, was noted as a key success factor. Differences in vaccination practices and veal calf rearing systems compared to Wales were also explored.

Overview of Companion Animal AMR work in the UK: Tamsin Dewé

The VMD team described their structure and surveillance activities, emphasizing the lack of comprehensive AMR data in companion animals and the need for better usage and resistance monitoring. Sales data indicate reductions in antibiotic use in dogs but stable levels in cats, with disproportionately high use of critically important antibiotics in cats due to long-acting formulations. 

Initiatives like the private labs project and pilot surveillance programmes aim to collect clinical AMR data to inform stewardship.

Presentation from RUMA Companion Animal Group: Steve Howard

RUMA highlighted the development of targets for antimicrobial use reduction in companion animals, including a 30% overall reduction in dogs and cats over five years, with a 50% reduction in critically important antibiotic use in cats. 

Focus areas for stewardship include bite wounds and abscesses in cats and acute diarrhoea in dogs, conditions where antibiotics are often overused. The importance of communication, clinician reassurance, and behaviour change strategies was stressed. Disposal campaigns for unused medicines were also noted as part of responsible use efforts.

Overview of prescribing surveillance: Alan Radford

An overview of electronic health record data collection from veterinary practices was provided, illustrating how diagnostic and prescribing data are aggregated for research and stewardship. The data include millions of records from cats and dogs, enabling analysis of antibiotic use patterns, clinical indications, and resistance trends. Interactive dashboards allow practices to benchmark their antibiotic use and target interventions. 

Qualitative research on prescribing decisions revealed factors influencing the use of critically important antibiotics, such as treating older animals or last-resort cases. Advanced analytics, including artificial intelligence, are being explored to support clinical decision-making and improve documentation standards.

Why has the VPC Network been so successful?: Alison Bard

The success of the Veterinary Prescribing Champions (VPC) network in Wales was discussed, highlighting its role in upskilling vets, fostering peer-to-peer learning, and promoting stewardship action plans tailored to local practice contexts. 

The network’s achievements are attributed to factors such as alignment with vets’ professional values, strong community identity, meaningful engagement, and sustained commitment. The network benefits from a supportive Welsh Government funding environment and integration with other initiatives. Challenges remain in extending stewardship culture throughout entire practices and teams, with ongoing efforts to enhance support and embed responsible use across veterinary services.

Workshop: Chair, Simon Rolfe

Opening Remarks: Richard Irvine, CVO Wales

The session began with introductions and acknowledgments of the attendees' efforts in contributing to what was described as a "world leading" AMR programme in Wales. The importance of collaborative work to protect medicines, animal welfare, and public health was emphasized, along with recognition of the participants' leadership roles and networks that support this work. The workshop was introduced as a platform to continue discussions from the morning presentations and to gather input on key questions related to AMR and companion animals.

Workshop Discussion and Participant Engagement

The workshop employed interactive polling (Mentimeter) to assess views on whether enough is currently being done to tackle AMR. Responses suggested that while significant activity is underway, there is consensus that more work remains, especially in improving collaboration and integration of efforts rather than simply increasing quantity. Participants highlighted the ongoing nature of AMR challenges, noting that antimicrobial resistance has been part of ecological and evolutionary processes since antimicrobials were first used.

The UK National Action Plan (NAP) on AMR was discussed, with participants generally familiar with its content and alignment with animal health priorities in Wales. The relevance of the NAP to applied delivery models was noted, indicating a need to make the plan's objectives more accessible and relevant to practitioners and researchers alike.

Defining Companion Animal Boundaries

A significant portion of the discussion focused on defining the scope of "companion animals" within AMR work. Participants debated whether distinctions should be based on the animals' purpose, living conditions, or species. For example, horses used for racing might be classified differently from pets like ferrets or guinea pigs due to differences in management and antimicrobial use pressures. There was consensus that while some compartmentalisation is necessary for targeted messaging and interventions, rigid boundaries may be artificial and challenging to maintain. The emotional connection between owners and companion animals was recognized as influencing communication strategies and stewardship efforts.

The group also considered the relationship between companion animals and food-producing animals, noting regulatory and surveillance frameworks that differentiate these categories but emphasizing the shared principles of antimicrobial stewardship across sectors. The need to align messaging and approaches while tailoring communication to different audiences was stressed.

Stakeholders and Roles in AMR Efforts

Participants identified various organisations and stakeholders that should be involved in AMR discussions related to companion animals, including veterinary practitioners, pharmaceutical companies, diagnostic laboratories, and the pet-owning public. The importance of collaboration and avoiding duplication or dilution of efforts was a recurring theme.

The role of this group in companion animal AMR was debated, with some expressing concern about overextending resources and risking progress made in the farm animal sector. Others argued that collaboration and shared learning could benefit both sectors, particularly given the One Health approach to AMR. The group recognized that while the core messages of antimicrobial stewardship are consistent, delivery and engagement strategies must be adapted to different contexts and audiences.

Leadership and Influence on AMR Change

A ranking exercise explored perceptions of who should lead or influence change in AMR practices. Veterinarians and government bodies were seen as key actors, with the general public also playing a role, especially in companion animal contexts. The discussion acknowledged the complexity of command-and-control structures in human health compared to the more collaborative animal health system in Wales, which has contributed to successes in AMR management. The importance of educating and engaging pet owners, who often have limited baseline knowledge about AMR, was highlighted as a critical challenge.

Future Directions and Group Identity

The meeting concluded with reflections on the group's identity and future activities. There was agreement on the appetite for expanding AMR work in companion animals and equines, balanced with caution to protect achievements in livestock sectors. Suggestions included involving lay pet owner representatives and considering the diversity of companion animal practices, including corporate and independent veterinary practices.

A pilot study funded by Aberystwyth University was announced, aiming to assess the needs and appetite for a companion animal AMR network in Wales. The group planned to circulate workshop questions via email for further input and to summarize findings in a forthcoming paper by a new PhD placement focused on companion animals.

Closing Remarks: Sian Timms

Sian Timms expressed appreciation to all attendees for their participation and noted the productivity of the day's proceedings. She extended best wishes for the Christmas break and confirmed that dates for the next meeting would be distributed prior to the new year.

AOB

To be covered via email.